<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37174703</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>02</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Molecular Chaperones' Potential against Defective Proteostasis of Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1302</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12091302</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neuronal degenerative condition identified via a build-up of mutant aberrantly folded proteins. The native folding of polypeptides is mediated by molecular chaperones, preventing their pathogenic aggregation. The mutant protein expression in ALS is linked with the entrapment and depletion of chaperone capacity. The lack of a thorough understanding of chaperones' involvement in ALS pathogenesis presents a significant challenge in its treatment. Here, we review how the accumulation of the ALS-linked mutant FUS, TDP-43, SOD1, and C9orf72 proteins damage cellular homeostasis mechanisms leading to neuronal loss. Further, we discuss how the HSP70 and DNAJ family co-chaperones can act as potential targets for reducing misfolded protein accumulation in ALS. Moreover, small HSPB1 and HSPB8 chaperones can facilitate neuroprotection and prevent stress-associated misfolded protein apoptosis. Designing therapeutic strategies by pharmacologically enhancing cellular chaperone capacity to reduce mutant protein proteotoxic effects on ALS pathomechanisms can be a considerable advancement. Chaperones, apart from directly interacting with misfolded proteins for protein quality control, can also filter their toxicity by initiating strong stress-response pathways, modulating transcriptional expression profiles, and promoting anti-apoptotic functions. Overall, these properties of chaperones make them an attractive target for gaining fundamental insights into misfolded protein disorders and designing more effective therapies against ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kinger</LastName><ForeName>Sumit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur 342037, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubey</LastName><ForeName>Ankur Rakesh</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur 342037, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Prashant</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur 342037, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagtap</LastName><ForeName>Yuvraj Anandrao</ForeName><Initials>YA</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur 342037, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choudhary</LastName><ForeName>Akash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur 342037, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Amit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Discipline of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore 453552, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prajapati</LastName><ForeName>Vijay Kumar</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer 305817, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhiman</LastName><ForeName>Rohan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory of Mycobacterial Immunology, Department of Life Science, National Institute of Technology, Rourkela 769008, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Amit</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9401-4400</Identifier><AffiliationInfo><Affiliation>Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur 342037, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018832">Molecular Chaperones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050956">HSP40 Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050505">Mutant Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074702" MajorTopicYN="N">Proteostasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018832" MajorTopicYN="N">Molecular Chaperones</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050956" MajorTopicYN="N">HSP40 Heat-Shock Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050505" MajorTopicYN="N">Mutant Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">HSP27</Keyword><Keyword MajorTopicYN="N">HSP40</Keyword><Keyword MajorTopicYN="N">HSP70</Keyword><Keyword MajorTopicYN="N">HSPB8</Keyword><Keyword MajorTopicYN="N">chaperones</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>15</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37174703</ArticleId><ArticleId IdType="pmc">PMC10177248</ArticleId><ArticleId IdType="doi">10.3390/cells12091302</ArticleId><ArticleId IdType="pii">cells12091302</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van den Bos M.A.J., Geevasinga N., Higashihara M., Menon P., Vucic S. Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques. Int. J. Mol. Sci. 2019;20:2818. doi: 10.3390/ijms20112818.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112818</ArticleId><ArticleId IdType="pmc">PMC6600525</ArticleId><ArticleId IdType="pubmed">31185581</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Prim. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam O.H., Rozhkov N.V., Shaw R., Kim D., Hubbard I., Fennessey S., Propp N., Consortium N.A., Fagegaltier D., Harris B.T., et al. Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia. Cell Rep. 2019;29:1164&#x2013;1177.e5. doi: 10.1016/j.celrep.2019.09.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito H., Kamei T., Odake S., Nakano M., Okeda R., Kohriki S., Kawachi J., Onders R.P., Yoshii F. An Autopsy Case of Amyotrophic Lateral Sclerosis with Diaphragm Pacing. Intern. Med. 2016;55:3511&#x2013;3513. doi: 10.2169/internalmedicine.55.7130.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.55.7130</ArticleId><ArticleId IdType="pmc">PMC5216153</ArticleId><ArticleId IdType="pubmed">27904119</ArticleId></ArticleIdList></Reference><Reference><Citation>Pare B., Lehmann M., Beaudin M., Nordstrom U., Saikali S., Julien J.P., Gilthorpe J.D., Marklund S.L., Cashman N.R., Andersen P.M., et al. Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis. Sci. Rep. 2018;8:14223. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Hewitt C., Highley J.R., Brockington A., Milano A., Man S., Martindale J., Hartley J., Walsh T., Gelsthorpe C., et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain. 2012;135:751&#x2013;764. doi: 10.1093/brain/awr365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L., Drexler H.C.A., Wang J., Tripathi P., Distler T., Heisterkamp P., Anderson E.N., Kour S., Moraiti A., Maharana S., et al. FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy. Acta Neuropathol. 2019;138:67&#x2013;84. doi: 10.1007/s00401-019-01998-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01998-x</ArticleId><ArticleId IdType="pmc">PMC6570784</ArticleId><ArticleId IdType="pubmed">30937520</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E., Bieniek K.F., Gendron T.F., Caulfield T., Lin W.L., Dejesus-Hernandez M., van Blitterswijk M.M., Jansen-West K., Paul J.W., 3rd, Rademakers R., et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77:639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.P., Yu S.H., Wei Q.Q., Cao B., Gu X.J., Chen X.P., Song W., Zhao B., Wu Y., Sun M.M., et al. Role of genetics in amyotrophic lateral sclerosis: A large cohort study in Chinese mainland population. J. Med. Genet. 2022;59:840&#x2013;849. doi: 10.1136/jmedgenet-2021-107965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2021-107965</ArticleId><ArticleId IdType="pmc">PMC9411893</ArticleId><ArticleId IdType="pubmed">34544842</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassano M., Calvo A., Moglia C., Sbaiz L., Brunetti M., Barberis M., Casale F., Manera U., Vasta R., Canosa A., et al. Systematic evaluation of genetic mutations in ALS: A population-based study. J. Neurol. Neurosurg. Psychiatry. 2022;93:1190&#x2013;1193. doi: 10.1136/jnnp-2022-328931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-328931</ArticleId><ArticleId IdType="pmc">PMC9606529</ArticleId><ArticleId IdType="pubmed">35896380</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N., Nishiyama A., Warita H., Aoki M. Genetics of amyotrophic lateral sclerosis: Seeking therapeutic targets in the era of gene therapy. J. Hum. Genet. 2022;68:131&#x2013;152. doi: 10.1038/s10038-022-01055-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s10038-022-01055-8</ArticleId><ArticleId IdType="pmc">PMC9968660</ArticleId><ArticleId IdType="pubmed">35691950</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Ji Y., Tang L., Zhang N., He J., Ye S., Liu X., Fan D. Optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in China. Amyotroph Lateral Scler. Front. Degener. 2015;16:485&#x2013;489. doi: 10.3109/21678421.2015.1089909.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1089909</ArticleId><ArticleId IdType="pubmed">26503823</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson S.B., Downie J.M., Tsetsou S., Feusier J.E., Figueroa K.P., Bromberg M.B., Jorde L.B., Pulst S.M. The evolving genetic risk for sporadic ALS. Neurology. 2017;89:226&#x2013;233. doi: 10.1212/WNL.0000000000004109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004109</ArticleId><ArticleId IdType="pmc">PMC5513819</ArticleId><ArticleId IdType="pubmed">28642336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Cheng Y., Jia X., Liu X., Li X., Zhang K., Shen D., Liu M., Guan Y., Liu Q., et al. Four novel optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in Mainland China. Neurobiol. Aging. 2021;97:149.e141&#x2013;149.e148. doi: 10.1016/j.neurobiolaging.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.08.002</ArticleId><ArticleId IdType="pubmed">32893042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998;281:1851&#x2013;1854. doi: 10.1126/science.281.5384.1851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5384.1851</ArticleId><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston J.A., Dalton M.J., Gurney M.E., Kopito R.R. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2000;97:12571&#x2013;12576. doi: 10.1073/pnas.220417997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.220417997</ArticleId><ArticleId IdType="pmc">PMC18805</ArticleId><ArticleId IdType="pubmed">11050163</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.S., Snead D., Lee J.J., McCaffery J.M., Shorter J., Gitler A.D. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 2009;284:20329&#x2013;20339. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Fushimi K., Long C., Jayaram N., Chen X., Li L., Wu J.Y. Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy. Protein Cell. 2011;2:141&#x2013;149. doi: 10.1007/s13238-011-1014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-011-1014-5</ArticleId><ArticleId IdType="pmc">PMC3093303</ArticleId><ArticleId IdType="pubmed">21327870</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Weng S.M., Arzberger T., May S., Rentzsch K., Kremmer E., Schmid B., Kretzschmar H.A., Cruts M., Van Broeckhoven C., et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Gonzalez I., Soto C. Misfolded protein aggregates: Mechanisms, structures and potential for disease transmission. Semin Cell Dev. Biol. 2011;22:482&#x2013;487. doi: 10.1016/j.semcdb.2011.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2011.04.002</ArticleId><ArticleId IdType="pmc">PMC3175247</ArticleId><ArticleId IdType="pubmed">21571086</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Retzlaff M., Roos T., Frydman J. Cellular strategies of protein quality control. Cold Spring Harb. Perspect Biol. 2011;3:a004374. doi: 10.1101/cshperspect.a004374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a004374</ArticleId><ArticleId IdType="pmc">PMC3140689</ArticleId><ArticleId IdType="pubmed">21746797</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra R., Upadhyay A., Prajapati V.K., Mishra A. Proteasome-mediated proteostasis: Novel medicinal and pharmacological strategies for diseases. Med. Res. Rev. 2018;38:1916&#x2013;1973. doi: 10.1002/med.21502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21502</ArticleId><ArticleId IdType="pubmed">29719055</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaraj G.G., Hipp M.S., Hartl F.U. Functional Modules of the Proteostasis Network. Cold Spring Harb. Perspect Biol. 2020;12:a033951. doi: 10.1101/cshperspect.a033951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a033951</ArticleId><ArticleId IdType="pmc">PMC6942124</ArticleId><ArticleId IdType="pubmed">30833457</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanover A., Kwon Y.T. Protein Quality Control by Molecular Chaperones in Neurodegeneration. Front. Neurosci. 2017;11:185. doi: 10.3389/fnins.2017.00185.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00185</ArticleId><ArticleId IdType="pmc">PMC5382173</ArticleId><ArticleId IdType="pubmed">28428740</ArticleId></ArticleIdList></Reference><Reference><Citation>Muchowski P.J., Wacker J.L. Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci. 2005;6:11&#x2013;22. doi: 10.1038/nrn1587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1587</ArticleId><ArticleId IdType="pubmed">15611723</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., Gunther R., Jin M., Stanslowsky N., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Guo W., Mitra J., Hegde P.M., Vandoorne T., Eckelmann B.J., Mitra S., Tomkinson A.E., Van Den Bosch L., Hegde M.L. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis. Nat. Commun. 2018;9:3683. doi: 10.1038/s41467-018-06111-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06111-6</ArticleId><ArticleId IdType="pmc">PMC6134028</ArticleId><ArticleId IdType="pubmed">30206235</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J., Hegde M.L. A Commentary on TDP-43 and DNA Damage Response in Amyotrophic Lateral Sclerosis. J. Exp. Neurosci. 2019;13:1179069519880166. doi: 10.1177/1179069519880166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179069519880166</ArticleId><ArticleId IdType="pmc">PMC6791036</ArticleId><ArticleId IdType="pubmed">31656396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J., Guerrero E.N., Hegde P.M., Liachko N.F., Wang H., Vasquez V., Gao J., Pandey A., Taylor J.P., Kraemer B.C., et al. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc. Natl. Acad. Sci. USA. 2019;116:4696&#x2013;4705. doi: 10.1073/pnas.1818415116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818415116</ArticleId><ArticleId IdType="pmc">PMC6410842</ArticleId><ArticleId IdType="pubmed">30770445</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade N.S., Ramic M., Esanov R., Liu W., Rybin M.J., Gaidosh G., Abdallah A., Del&#x2019;Olio S., Huff T.C., Chee N.T., et al. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD. Mol. Neurodegener. 2020;15:13. doi: 10.1186/s13024-020-00365-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00365-9</ArticleId><ArticleId IdType="pmc">PMC7041170</ArticleId><ArticleId IdType="pubmed">32093728</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Song M., Moh S., Kim H., Kim D.H. Cytoplasmic Restriction of Mutated SOD1 Impairs the DNA Repair Process in Spinal Cord Neurons. Cells. 2019;8:1502. doi: 10.3390/cells8121502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8121502</ArticleId><ArticleId IdType="pmc">PMC6952796</ArticleId><ArticleId IdType="pubmed">31771229</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordoni M., Pansarasa O., Dell&#x2019;Orco M., Crippa V., Gagliardi S., Sproviero D., Bernuzzi S., Diamanti L., Ceroni M., Tedeschi G., et al. Nuclear Phospho-SOD1 Protects DNA from Oxidative Stress Damage in Amyotrophic Lateral Sclerosis. J. Clin. Med. 2019;8:729. doi: 10.3390/jcm8050729.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8050729</ArticleId><ArticleId IdType="pmc">PMC6572067</ArticleId><ArticleId IdType="pubmed">31121901</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.C., Kumar M.S., Ramesh N., Anderson E.N., Nguyen A.T., Kim B., Cheung S., McDonough J.A., Skarnes W.C., Lopez-Gonzalez R., et al. Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway. Nat. Neurosci. 2021;24:1077&#x2013;1088. doi: 10.1038/s41593-021-00859-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00859-9</ArticleId><ArticleId IdType="pmc">PMC8832378</ArticleId><ArticleId IdType="pubmed">34059832</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.C., Zhang Y., Umoh M.E., Vaughan S.W., Lorenzini I., Liu F., Sayegh M., Donlin-Asp P.G., Chen Y.H., Duong D.M., et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Yamashita T., Nakano Y., Morihara R., Li X., Feng T., Liu X., Huang Y., Fukui Y., Hishikawa N., et al. Aberrant distributions of nuclear pore complex proteins in ALS mice and ALS patients. Neuroscience. 2017;350:158&#x2013;168. doi: 10.1016/j.neuroscience.2017.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.03.024</ArticleId><ArticleId IdType="pubmed">28344074</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Y., Wang J., Henderson M.J., Yang P., Hagen B.M., Siddique T., Vogel B.E., Deng H.X., Fang S. Nuclear export of misfolded SOD1 mediated by a normally buried NES-like sequence reduces proteotoxicity in the nucleus. Elife. 2017;6:e23759. doi: 10.7554/eLife.23759.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.23759</ArticleId><ArticleId IdType="pmc">PMC5449186</ArticleId><ArticleId IdType="pubmed">28463106</ArticleId></ArticleIdList></Reference><Reference><Citation>Gertz B., Wong M., Martin L.J. Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice. J. Neuropathol. Exp. Neurol. 2012;71:162&#x2013;177. doi: 10.1097/NEN.0b013e318244b635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318244b635</ArticleId><ArticleId IdType="pmc">PMC3432922</ArticleId><ArticleId IdType="pubmed">22249462</ArticleId></ArticleIdList></Reference><Reference><Citation>Palancade B., Liu X., Garcia-Rubio M., Aguilera A., Zhao X., Doye V. Nucleoporins prevent DNA damage accumulation by modulating Ulp1-dependent sumoylation processes. Mol. Biol. Cell. 2007;18:2912&#x2013;2923. doi: 10.1091/mbc.e07-02-0123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e07-02-0123</ArticleId><ArticleId IdType="pmc">PMC1949349</ArticleId><ArticleId IdType="pubmed">17538013</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan S., Rollinson S., Hobbs E., Pickering-Brown S. C9orf72 dipeptides disrupt the nucleocytoplasmic transport machinery and cause TDP-43 mislocalisation to the cytoplasm. Sci. Rep. 2022;12:4799. doi: 10.1038/s41598-022-08724-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-08724-w</ArticleId><ArticleId IdType="pmc">PMC8938440</ArticleId><ArticleId IdType="pubmed">35314728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Donnelly C.J., Haeusler A.R., Grima J.C., Machamer J.B., Steinwald P., Daley E.L., Miller S.J., Cunningham K.M., Vidensky S., et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovicic A., Mertens J., Boeynaems S., Bogaert E., Chai N., Yamada S.B., Paul J.W., 3rd, Sun S., Herdy J.R., Bieri G., et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 2015;18:1226&#x2013;1229. doi: 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Lu Y., Lopez-Gonzalez R., Kim N.C., Almeida S., Lee K.H., Badders N., Valentine M., Miller B.L., Wong P.C., et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Daigle J.G., Cunningham K.M., Coyne A.N., Ruan K., Grima J.C., Bowen K.E., Wadhwa H., Yang P., Rigo F., et al. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport. Cell. 2018;173:958&#x2013;971 e917. doi: 10.1016/j.cell.2018.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.025</ArticleId><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J., Van Den Bosch L. The Role of Nucleocytoplasmic Transport Defects in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2021;22:12175. doi: 10.3390/ijms222212175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222212175</ArticleId><ArticleId IdType="pmc">PMC8620263</ArticleId><ArticleId IdType="pubmed">34830069</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J., Vercruysse T., Boeynaems S., Van Damme P., Daelemans D., Van Den Bosch L. Cellular Stress Induces Nucleocytoplasmic Transport Deficits Independent of Stress Granules. Biomedicines. 2022;10:1057. doi: 10.3390/biomedicines10051057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10051057</ArticleId><ArticleId IdType="pmc">PMC9138870</ArticleId><ArticleId IdType="pubmed">35625794</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J., Vercruysse T., Boeynaems S., Sicart A., Van Damme P., Daelemans D., Van Den Bosch L. C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocytoplasmic transport. Sci. Rep. 2019;9:15728. doi: 10.1038/s41598-019-52035-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-52035-6</ArticleId><ArticleId IdType="pmc">PMC6823349</ArticleId><ArticleId IdType="pubmed">31673013</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedyukina D.V., Cavagnero S. Protein folding at the exit tunnel. Annu. Rev. Biophys. 2011;40:337&#x2013;359. doi: 10.1146/annurev-biophys-042910-155338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biophys-042910-155338</ArticleId><ArticleId IdType="pmc">PMC5807062</ArticleId><ArticleId IdType="pubmed">21370971</ArticleId></ArticleIdList></Reference><Reference><Citation>Protter D.S.W., Parker R. Principles and Properties of Stress Granules. Trends Cell Biol. 2016;26:668&#x2013;679. doi: 10.1016/j.tcb.2016.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2016.05.004</ArticleId><ArticleId IdType="pmc">PMC4993645</ArticleId><ArticleId IdType="pubmed">27289443</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateju D., Franzmann T.M., Patel A., Kopach A., Boczek E.E., Maharana S., Lee H.O., Carra S., Hyman A.A., Alberti S. An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function. EMBO J. 2017;36:1669&#x2013;1687. doi: 10.15252/embj.201695957.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201695957</ArticleId><ArticleId IdType="pmc">PMC5470046</ArticleId><ArticleId IdType="pubmed">28377462</ArticleId></ArticleIdList></Reference><Reference><Citation>An H., Litscher G., Watanabe N., Wei W., Hashimoto T., Iwatsubo T., Buchman V.L., Shelkovnikova T.A. ALS-linked cytoplasmic FUS assemblies are compositionally different from physiological stress granules and sequester hnRNPA3, a novel modifier of FUS toxicity. Neurobiol. Dis. 2022;162:105585. doi: 10.1016/j.nbd.2021.105585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105585</ArticleId><ArticleId IdType="pmc">PMC8799889</ArticleId><ArticleId IdType="pubmed">34915152</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradaran-Heravi Y., Van Broeckhoven C., van der Zee J. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum. Neurobiol. Dis. 2020;134:104639. doi: 10.1016/j.nbd.2019.104639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104639</ArticleId><ArticleId IdType="pubmed">31626953</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Kovacs D., Konijnenberg A., Timmerman E., Volkov A., Guharoy M., De Decker M., Jaspers T., Ryan V.H., et al. Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics. Mol. Cell. 2017;65:1044&#x2013;1055.e5. doi: 10.1016/j.molcel.2017.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.02.013</ArticleId><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J., Cook C., Gendron T.F., Jansen-West K., Del Rosso G., Daughrity L.M., Castanedes-Casey M., Kurti A., Stankowski J.N., Disney M.D., et al. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Mol. Neurodegener. 2019;14:9. doi: 10.1186/s13024-019-0310-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0310-z</ArticleId><ArticleId IdType="pmc">PMC6377782</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L., Bilgutay A., Zhang Y.J., Vanderweyde T., Citro A., Mehta T., Zaarur N., McKee A., Bowser R., Sherman M., et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: Analysis of cultured cells and pathological brain tissue. PLoS ONE. 2010;5:e13250. doi: 10.1371/journal.pone.0013250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013250</ArticleId><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubinski A., Gagne M., Peyrard S., Gordon D., Talbot K., Velde C.V. Stress granule assembly in vivo is deficient in the CNS of mutant TDP-43 ALS mice. Hum. Mol. Genet. 2022;32:319&#x2013;332. doi: 10.1093/hmg/ddac206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddac206</ArticleId><ArticleId IdType="pmc">PMC9840205</ArticleId><ArticleId IdType="pubmed">35994036</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalfallah Y., Kuta R., Grasmuck C., Prat A., Durham H.D., Vande Velde C. TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci. Rep. 2018;8:7551. doi: 10.1038/s41598-018-25767-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25767-0</ArticleId><ArticleId IdType="pmc">PMC5953947</ArticleId><ArticleId IdType="pubmed">29765078</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mena L., Lopez-Scarim J., Rincon-Limas D.E. TDP-43 and ER Stress in Neurodegeneration: Friends or Foes? Front. Mol. Neurosci. 2021;14:772226. doi: 10.3389/fnmol.2021.772226.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.772226</ArticleId><ArticleId IdType="pmc">PMC8573113</ArticleId><ArticleId IdType="pubmed">34759799</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRocca T.J., Mariani A., Watkins L.R., Link C.D. TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes. Neurobiol. Dis. 2019;132:104514. doi: 10.1016/j.nbd.2019.104514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104514</ArticleId><ArticleId IdType="pmc">PMC6834892</ArticleId><ArticleId IdType="pubmed">31229690</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg M.A., Soo K.Y., Walker A.K., Pham H., Orian J., Horne M.K., Warraich S.T., Williams K.L., Blair I.P., Atkin J.D. Mutant FUS induces endoplasmic reticulum stress in amyotrophic lateral sclerosis and interacts with protein disulfide-isomerase. Neurobiol. Aging. 2012;33:2855&#x2013;2868. doi: 10.1016/j.neurobiolaging.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.02.009</ArticleId><ArticleId IdType="pubmed">22459602</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T., Qamar S., Lin J.Q., Schierle G.S., Rees E., Miyashita A., Costa A.R., Dodd R.B., Chan F.T., Michel C.H., et al. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function. Neuron. 2015;88:678&#x2013;690. doi: 10.1016/j.neuron.2015.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.030</ArticleId><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonobe Y., Ghadge G., Masaki K., Sendoel A., Fuchs E., Roos R.P. Translation of dipeptide repeat proteins from the C9ORF72 expanded repeat is associated with cellular stress. Neurobiol. Dis. 2018;116:155&#x2013;165. doi: 10.1016/j.nbd.2018.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.05.009</ArticleId><ArticleId IdType="pmc">PMC6331062</ArticleId><ArticleId IdType="pubmed">29792928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonobe Y., Aburas J., Krishnan G., Fleming A.C., Ghadge G., Islam P., Warren E.C., Gu Y., Kankel M.W., Brown A.E.X., et al. A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation. Nat. Commun. 2021;12:6025. doi: 10.1038/s41467-021-26303-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26303-x</ArticleId><ArticleId IdType="pmc">PMC8519953</ArticleId><ArticleId IdType="pubmed">34654821</ArticleId></ArticleIdList></Reference><Reference><Citation>Gami-Patel P., van Dijken I., Meeter L.H., Melhem S., Morrema T.H.J., Scheper W., van Swieten J.C., Rozemuller A.J.M., Dijkstra A.A., Hoozemans J.J.M. Unfolded protein response activation in C9orf72 frontotemporal dementia is associated with dipeptide pathology and granulovacuolar degeneration in granule cells. Brain Pathol. 2021;31:163&#x2013;173. doi: 10.1111/bpa.12894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12894</ArticleId><ArticleId IdType="pmc">PMC7891436</ArticleId><ArticleId IdType="pubmed">32865835</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y.N., Kavianpour S., Zhang T., Zhang X., Nguyen D., Thombre R., He L., Wang J. MARK2 phosphorylates eIF2alpha in response to proteotoxic stress. PLoS Biol. 2021;19:e3001096. doi: 10.1371/journal.pbio.3001096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001096</ArticleId><ArticleId IdType="pmc">PMC7951919</ArticleId><ArticleId IdType="pubmed">33705388</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Lillo C., Jonsson P.A., Vande Velde C., Ward C.M., Miller T.M., Subramaniam J.R., Rothstein J.D., Marklund S., Andersen P.M., et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron. 2004;43:5&#x2013;17. doi: 10.1016/j.neuron.2004.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.016</ArticleId><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Yan S., Zhang Z. Maintaining the balance of TDP-43, mitochondria, and autophagy: A promising therapeutic strategy for neurodegenerative diseases. Transl. Neurodegener. 2020;9:40. doi: 10.1186/s40035-020-00219-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-020-00219-w</ArticleId><ArticleId IdType="pmc">PMC7597011</ArticleId><ArticleId IdType="pubmed">33126923</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Lu Y., Gendron T.F., Karydas A., Tran H., Yang D., Petrucelli L., Miller B.L., Almeida S., Gao F.B. Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M., D&#x2019;Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Beal M.F., Manfredi G. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 2002;277:29626&#x2013;29633. doi: 10.1074/jbc.M203065200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M203065200</ArticleId><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai Y.L., Coady T.H., Lu L., Zheng D., Alland I., Tian B., Shneider N.A., Manley J.L. ALS/FTD-associated protein FUS induces mitochondrial dysfunction by preferentially sequestering respiratory chain complex mRNAs. Genes Dev. 2020;34:785&#x2013;805. doi: 10.1101/gad.335836.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.335836.119</ArticleId><ArticleId IdType="pmc">PMC7263147</ArticleId><ArticleId IdType="pubmed">32381627</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R., Barbagallo P., Talbot K. The Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS. Front. Cell Neurosci. 2021;15:653688. doi: 10.3389/fncel.2021.653688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.653688</ArticleId><ArticleId IdType="pmc">PMC8047135</ArticleId><ArticleId IdType="pubmed">33867942</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T., Liu H., Itoh K., Oh S., Zhao L., Murata D., Sesaki H., Hartung T., Na C.H., Wang J. C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly. Cell Metab. 2021;33:531&#x2013;546.e9. doi: 10.1016/j.cmet.2021.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC8579819</ArticleId><ArticleId IdType="pubmed">33545050</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucini C.B., Braun R.J. Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies. Biomedicines. 2021;9:376. doi: 10.3390/biomedicines9040376.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9040376</ArticleId><ArticleId IdType="pmc">PMC8066287</ArticleId><ArticleId IdType="pubmed">33918437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang L., Lu J., Siedlak S.L., Fujioka H., Liang J., Jiang S., Ma X., Jiang Z., da Rocha E.L., et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 2016;22:869&#x2013;878. doi: 10.1038/nm.4130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A., Arbel N., Da Cruz S., Ilieva H., Yamanaka K., Shoshan-Barmatz V., Cleveland D.W. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron. 2010;67:575&#x2013;587. doi: 10.1016/j.neuron.2010.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.019</ArticleId><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorov D.B., Juhaszova M., Sollott S.J. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 2014;94:909&#x2013;950. doi: 10.1152/physrev.00026.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00026.2013</ArticleId><ArticleId IdType="pmc">PMC4101632</ArticleId><ArticleId IdType="pubmed">24987008</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent A.C., El Baradie K.B.Y., Hamrick M.W. Targeting the Mitochondrial Permeability Transition Pore to Prevent Age-Associated Cell Damage and Neurodegeneration. Oxid Med. Cell Longev. 2021;2021:6626484. doi: 10.1155/2021/6626484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6626484</ArticleId><ArticleId IdType="pmc">PMC7861926</ArticleId><ArticleId IdType="pubmed">33574977</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallstig E., McCabe B.D., Schneider B.L. The Links between ALS and NF-kappaB. Int. J. Mol. Sci. 2021;22:3875. doi: 10.3390/ijms22083875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22083875</ArticleId><ArticleId IdType="pmc">PMC8070122</ArticleId><ArticleId IdType="pubmed">33918092</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelini D.F., De Angelis F., Vacca V., Piras E., Parisi C., Nutini M., Spalloni A., Pagano F., Longone P., Battistini L., et al. Very Early Involvement of Innate Immunity in Peripheral Nerve Degeneration in SOD1-G93A Mice. Front. Immunol. 2020;11:575792. doi: 10.3389/fimmu.2020.575792.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.575792</ArticleId><ArticleId IdType="pmc">PMC7714949</ArticleId><ArticleId IdType="pubmed">33329541</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Cynader M.S., Jia W. TDP-43 Inhibits NF-kappaB Activity by Blocking p65 Nuclear Translocation. PLoS ONE. 2015;10:e0142296. doi: 10.1371/journal.pone.0142296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0142296</ArticleId><ArticleId IdType="pmc">PMC4646651</ArticleId><ArticleId IdType="pubmed">26571498</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Bell S., Wang J., Wen S., Baloh R.H., Appel S.H. TDP-43 activates microglia through NF-kappaB and NLRP3 inflammasome. Exp. Neurol. 2015;273:24&#x2013;35. doi: 10.1016/j.expneurol.2015.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.07.019</ArticleId><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.H., Davidson S., Harapas C.R., Hilton J.B., Mlodzianoski M.J., Laohamonthonkul P., Louis C., Low R.R.J., Moecking J., De Nardo D., et al. TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. Cell. 2020;183:636&#x2013;649.e18. doi: 10.1016/j.cell.2020.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A., McAvoy K., Krishnamurthy K., Trotti D., Pasinelli P. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia. 2018;66:1016&#x2013;1033. doi: 10.1002/glia.23298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23298</ArticleId><ArticleId IdType="pmc">PMC5873384</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId></ArticleIdList></Reference><Reference><Citation>Trageser K.J., Smith C., Herman F.J., Ono K., Pasinetti G.M. Mechanisms of Immune Activation by c9orf72-Expansions in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Neurosci. 2019;13:1298. doi: 10.3389/fnins.2019.01298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01298</ArticleId><ArticleId IdType="pmc">PMC6914852</ArticleId><ArticleId IdType="pubmed">31920478</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L., Van Damme P., Bogaert E., Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta. 2006;1762:1068&#x2013;1082. doi: 10.1016/j.bbadis.2006.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.05.002</ArticleId><ArticleId IdType="pubmed">16806844</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G., Holodkov N., Klima R., Feiguin F. TDP-43 regulates GAD1 mRNA splicing and GABA signaling in Drosophila CNS. Sci. Rep. 2021;11:18761. doi: 10.1038/s41598-021-98241-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-98241-z</ArticleId><ArticleId IdType="pmc">PMC8455590</ArticleId><ArticleId IdType="pubmed">34548578</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J., Huang C., Bi F., Wu Q., Huang B., Liu X., Li F., Zhou H., Xia X.G. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J. 2013;32:1917&#x2013;1926. doi: 10.1038/emboj.2013.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.122</ArticleId><ArticleId IdType="pmc">PMC3981181</ArticleId><ArticleId IdType="pubmed">23714777</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer M.S., Reale L.A., Lewis K.E., Walker A.K., Dickson T.C., Woodhouse A., Blizzard C.A. Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex. J. Neurochem. 2021;157:1300&#x2013;1315. doi: 10.1111/jnc.15214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15214</ArticleId><ArticleId IdType="pubmed">33064315</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh J.N., Tosolini A.P., Gordon D., Devoy A., Fratta P., Fisher E.M.C., Talbot K., Schiavo G. Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes. Cell Rep. 2020;30:3655&#x2013;3662.e2. doi: 10.1016/j.celrep.2020.02.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.02.078</ArticleId><ArticleId IdType="pmc">PMC7090381</ArticleId><ArticleId IdType="pubmed">32187538</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan K., Murphy J., Singh A., Mitchell C.S. Astrocyte-Mediated Neuromodulatory Regulation in Preclinical ALS: A Metadata Analysis. Front. Cell Neurosci. 2018;12:491. doi: 10.3389/fncel.2018.00491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00491</ArticleId><ArticleId IdType="pmc">PMC6305074</ArticleId><ArticleId IdType="pubmed">30618638</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X., Wang S., Qi Y., Wang X., Jiang H., Wang T., Yang Y., Wang Y., Zhang C., Feng H. Astrocyte elevated gene-1 is a novel regulator of astrogliosis and excitatory amino acid transporter-2 via interplaying with nuclear factor-kappaB signaling in astrocytes from amyotrophic lateral sclerosis mouse model with hSOD1(G93A) mutation. Mol. Cell Neurosci. 2018;90:1&#x2013;11. doi: 10.1016/j.mcn.2018.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2018.05.004</ArticleId><ArticleId IdType="pubmed">29777762</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd A.C., Hardingham G.E. The Regulation of Astrocytic Glutamate Transporters in Health and Neurodegenerative Diseases. Int. J. Mol. Sci. 2020;21:9607. doi: 10.3390/ijms21249607.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249607</ArticleId><ArticleId IdType="pmc">PMC7766851</ArticleId><ArticleId IdType="pubmed">33348528</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M., Zappettini S., Onofri F., Musazzi L., Tardito D., Bonifacino T., Messa M., Racagni G., Usai C., Benfenati F., et al. Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2011;116:1028&#x2013;1042. doi: 10.1111/j.1471-4159.2010.07155.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.07155.x</ArticleId><ArticleId IdType="pubmed">21175617</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J., Sanjuan-Ruiz I., Kan V., Megat S., De Rossi P., Dieterle S., Cassel R., Jamet M., Kessler P., Wiesner D., et al. Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects. Nat. Commun. 2021;12:3028. doi: 10.1038/s41467-021-23187-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23187-9</ArticleId><ArticleId IdType="pmc">PMC8140148</ArticleId><ArticleId IdType="pubmed">34021132</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Xu J. C9orf72 Dipeptide Repeats Cause Selective Neurodegeneration and Cell-Autonomous Excitotoxicity in Drosophila Glutamatergic Neurons. J. Neurosci. 2018;38:7741&#x2013;7752. doi: 10.1523/JNEUROSCI.0908-18.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0908-18.2018</ArticleId><ArticleId IdType="pmc">PMC6705968</ArticleId><ArticleId IdType="pubmed">30037833</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Devlin A.C., Chouhan A.K., Selvaraj B.T., Stavrou M., Burr K., Brivio V., He X., Mehta A.R., Story D., et al. Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia. 2020;68:1046&#x2013;1064. doi: 10.1002/glia.23761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23761</ArticleId><ArticleId IdType="pmc">PMC7078830</ArticleId><ArticleId IdType="pubmed">31841614</ArticleId></ArticleIdList></Reference><Reference><Citation>Amalyan S., Tamboli S., Lazarevich I., Topolnik D., Bouman L.H., Topolnik L. Enhanced motor cortex output and disinhibition in asymptomatic female mice with C9orf72 genetic expansion. Cell Rep. 2022;40:111043. doi: 10.1016/j.celrep.2022.111043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111043</ArticleId><ArticleId IdType="pubmed">35793625</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin P., Bai D., Zhu L., Deng F., Guo X., Li B., Chen L., Li S., Li X.J. Cytoplasmic TDP-43 impairs the activity of the ubiquitin-proteasome system. Exp. Neurol. 2021;345:113833. doi: 10.1016/j.expneurol.2021.113833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2021.113833</ArticleId><ArticleId IdType="pubmed">34363810</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N.E., McAlary L., Lum J.S., Chisholm C.G., Warraich S.T., Blair I.P., Vine K.L., Saunders D.N., Yerbury J.J. Ubiquitin Homeostasis Is Disrupted in TDP-43 and FUS Cell Models of ALS. iScience. 2020;23:101700. doi: 10.1016/j.isci.2020.101700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101700</ArticleId><ArticleId IdType="pmc">PMC7644588</ArticleId><ArticleId IdType="pubmed">33196025</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemenschneider H., Guo Q., Bader J., Frottin F., Farny D., Kleinberger G., Haass C., Mann M., Hartl F.U., Baumeister W., et al. Gel-like inclusions of C-terminal fragments of TDP-43 sequester stalled proteasomes in neurons. EMBO Rep. 2022;23:e53890. doi: 10.15252/embr.202153890.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202153890</ArticleId><ArticleId IdType="pmc">PMC9171420</ArticleId><ArticleId IdType="pubmed">35438230</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi M.E., Cristofani R., Rusmini P., Meroni M., Ferrari V., Vezzoli G., Tedesco B., Piccolella M., Messi E., Galbiati M., et al. Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells. Sci. Rep. 2018;8:12390. doi: 10.1038/s41598-018-29658-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-29658-2</ArticleId><ArticleId IdType="pmc">PMC6098007</ArticleId><ArticleId IdType="pubmed">30120266</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M., Kurisu J., Tsukita K., Takahashi R. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J. Neurochem. 2002;83:1030&#x2013;1042. doi: 10.1046/j.1471-4159.2002.01211.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.01211.x</ArticleId><ArticleId IdType="pubmed">12437574</ArticleId></ArticleIdList></Reference><Reference><Citation>Massenzio F., Pena-Altamira E., Petralla S., Virgili M., Zuccheri G., Miti A., Polazzi E., Mengoni I., Piffaretti D., Monti B. Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose. Biochim. Biophys. Acta Mol. Basis Dis. 2018;1864:3771&#x2013;3785. doi: 10.1016/j.bbadis.2018.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2018.10.013</ArticleId><ArticleId IdType="pubmed">30315929</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakawa M., Ito D., Honda T., Kubo K., Noda M., Nakajima K., Suzuki N. Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS. Hum. Mol. Genet. 2015;24:1630&#x2013;1645. doi: 10.1093/hmg/ddu576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu576</ArticleId><ArticleId IdType="pubmed">25398948</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q., Wang H., Hao Z., Fu C., Hu Q., Gao F., Ren H., Chen D., Han J., Ying Z., et al. TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion. EMBO J. 2016;35:121&#x2013;142. doi: 10.15252/embj.201591998.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201591998</ArticleId><ArticleId IdType="pmc">PMC4718457</ArticleId><ArticleId IdType="pubmed">26702100</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo K.Y., Atkin J.D. Autophagy dysregulation by mutant fused in sarcoma--implications for amyotrophic lateral sclerosis. Cell Death Dis. 2015;6:e1945. doi: 10.1038/cddis.2015.311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2015.311</ArticleId><ArticleId IdType="pmc">PMC4632325</ArticleId><ArticleId IdType="pubmed">26512956</ArticleId></ArticleIdList></Reference><Reference><Citation>Filareti M., Luotti S., Pasetto L., Pignataro M., Paolella K., Messina P., Pupillo E., Filosto M., Lunetta C., Mandrioli J., et al. Decreased Levels of Foldase and Chaperone Proteins Are Associated with an Early-Onset Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2017;10:99. doi: 10.3389/fnmol.2017.00099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00099</ArticleId><ArticleId IdType="pmc">PMC5382314</ArticleId><ArticleId IdType="pubmed">28428745</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Morderer D., Wren M.C., Vettleson-Trutza S.A., Wang Y., Rabichow B.E., Salemi M.R., Phinney B.S., Oskarsson B., Dickson D.W., et al. Proximity proteomics of C9orf72 dipeptide repeat proteins identifies molecular chaperones as modifiers of poly-GA aggregation. Acta Neuropathol. Commun. 2022;10:22. doi: 10.1186/s40478-022-01322-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-022-01322-x</ArticleId><ArticleId IdType="pmc">PMC8842533</ArticleId><ArticleId IdType="pubmed">35164882</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharathi V., Bajpai A., Parappuram I.T., Patel B.K. Elevated constitutive expression of Hsp40 chaperone Sis1 reduces TDP-43 aggregation-induced oxidative stress in Ire1 pathway dependent-manner in yeast TDP-43 proteinopathy model of amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2022;595:28&#x2013;34. doi: 10.1016/j.bbrc.2022.01.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2022.01.073</ArticleId><ArticleId IdType="pubmed">35093637</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright G.S.A. Molecular and pharmacological chaperones for SOD1. Biochem. Soc. Trans. 2020;48:1795&#x2013;1806. doi: 10.1042/BST20200318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20200318</ArticleId><ArticleId IdType="pmc">PMC7458393</ArticleId><ArticleId IdType="pubmed">32794552</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozales K., Younis A., Saida N., Meller A., Goldman H., Kellerman L., Heinrich R., Berlin S., Shalgi R. Differential roles for DNAJ isoforms in HTT-polyQ and FUS aggregation modulation revealed by chaperone screens. Nat. Commun. 2022;13:516. doi: 10.1038/s41467-022-27982-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-27982-w</ArticleId><ArticleId IdType="pmc">PMC8792056</ArticleId><ArticleId IdType="pubmed">35082301</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Gu J., Wang C., Hu J., Zhang S., Liu C., Zhang S., Fang Y., Li D. Hsp70 exhibits a liquid-liquid phase separation ability and chaperones condensed FUS against amyloid aggregation. iScience. 2022;25:104356. doi: 10.1016/j.isci.2022.104356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104356</ArticleId><ArticleId IdType="pmc">PMC9127583</ArticleId><ArticleId IdType="pubmed">35620440</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer M.P., Bukau B. Hsp70 chaperones: Cellular functions and molecular mechanism. Cell Mol. Life Sci. 2005;62:670&#x2013;684. doi: 10.1007/s00018-004-4464-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-004-4464-6</ArticleId><ArticleId IdType="pmc">PMC2773841</ArticleId><ArticleId IdType="pubmed">15770419</ArticleId></ArticleIdList></Reference><Reference><Citation>Serlidaki D., van Waarde M., Rohland L., Wentink A.S., Dekker S.L., Kamphuis M.J., Boertien J.M., Brunsting J.F., Nillegoda N.B., Bukau B., et al. Functional diversity between HSP70 paralogs caused by variable interactions with specific co-chaperones. J. Biol. Chem. 2020;295:7301&#x2013;7316. doi: 10.1074/jbc.RA119.012449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.012449</ArticleId><ArticleId IdType="pmc">PMC7247296</ArticleId><ArticleId IdType="pubmed">32284329</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A., Iwasaki N., Kinjo M. Molecular chaperone HSP70 prevents formation of inclusion bodies of the 25-kDa C-terminal fragment of TDP-43 by preventing aggregate accumulation. Cell Stress Chaperones. 2018;23:1177&#x2013;1183. doi: 10.1007/s12192-018-0930-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-018-0930-1</ArticleId><ArticleId IdType="pmc">PMC6237682</ArticleId><ArticleId IdType="pubmed">30099725</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Wang C., Hu R., Li Y., Zhang S., Sun Y., Wang Q., Li D., Fang Y., Liu C. Hsp70 chaperones TDP-43 in dynamic, liquid-like phase and prevents it from amyloid aggregation. Cell Res. 2021;31:1024&#x2013;1027. doi: 10.1038/s41422-021-00526-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00526-5</ArticleId><ArticleId IdType="pmc">PMC8410890</ArticleId><ArticleId IdType="pubmed">34239072</ArticleId></ArticleIdList></Reference><Reference><Citation>Claes F., Rudyak S., Laird A.S., Louros N., Beerten J., Debulpaep M., Michiels E., van der Kant R., Van Durme J., De Baets G., et al. Exposure of a cryptic Hsp70 binding site determines the cytotoxicity of the ALS-associated SOD1-mutant A4V. Protein Eng. Des. Sel. 2019;32:443&#x2013;457. doi: 10.1093/protein/gzaa008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/protein/gzaa008</ArticleId><ArticleId IdType="pubmed">32399571</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Wang A., Zhong K., Qi S., Wei C., Shu X., Tu W.Y., Xu W., Xia C., Xiao Y., et al. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model. Neuron. 2021;109:1949&#x2013;1962.e6. doi: 10.1016/j.neuron.2021.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.04.023</ArticleId><ArticleId IdType="pubmed">33991504</ArticleId></ArticleIdList></Reference><Reference><Citation>Mylvaganam S., Earnshaw R., Heymann G., Kalia S.K., Kalia L.V. C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside. Curr. Neuropharmacol. 2021;19:1038&#x2013;1068. doi: 10.2174/1570159X18666201116145507.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X18666201116145507</ArticleId><ArticleId IdType="pmc">PMC8686314</ArticleId><ArticleId IdType="pubmed">33200713</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra A., Maheshwari M., Chhangani D., Fujimori-Tonou N., Endo F., Joshi A.P., Jana N.R., Yamanaka K. E6-AP association promotes SOD1 aggresomes degradation and suppresses toxicity. Neurobiol. Aging. 2013;34:1310.e1311&#x2013;1323. doi: 10.1016/j.neurobiolaging.2012.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.08.016</ArticleId><ArticleId IdType="pubmed">23040663</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi V., Mishra R., Upadhyay A., Amanullah A., Poluri K.M., Singh S., Kumar A., Mishra A. Polyphenolic flavonoid (Myricetin) upregulated proteasomal degradation mechanisms: Eliminates neurodegenerative proteins aggregation. J. Cell Physiol. 2019;234:20900&#x2013;20914. doi: 10.1002/jcp.28695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28695</ArticleId><ArticleId IdType="pubmed">31004355</ArticleId></ArticleIdList></Reference><Reference><Citation>Batulan Z., Shinder G.A., Minotti S., He B.P., Doroudchi M.M., Nalbantoglu J., Strong M.J., Durham H.D. High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1. J. Neurosci. 2003;23:5789&#x2013;5798. doi: 10.1523/JNEUROSCI.23-13-05789.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-13-05789.2003</ArticleId><ArticleId IdType="pmc">PMC6741252</ArticleId><ArticleId IdType="pubmed">12843283</ArticleId></ArticleIdList></Reference><Reference><Citation>Okado-Matsumoto A., Fridovich I. Amyotrophic lateral sclerosis: A proposed mechanism. Proc. Natl. Acad. Sci. USA. 2002;99:9010&#x2013;9014. doi: 10.1073/pnas.132260399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.132260399</ArticleId><ArticleId IdType="pmc">PMC124414</ArticleId><ArticleId IdType="pubmed">12060716</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S., Caputi F., Pignataro A., Amadio S., Fabbrizio P., Ammassari-Teule M., Volonte C. Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS. Int. J. Mol. Sci. 2019;20:3793. doi: 10.3390/ijms20153793.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20153793</ArticleId><ArticleId IdType="pmc">PMC6696457</ArticleId><ArticleId IdType="pubmed">31382568</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke B.E., Gil R.S., Yip J., Kalmar B., Greensmith L. Regional differences in the inflammatory and heat shock response in glia: Implications for ALS. Cell Stress Chaperones. 2019;24:857&#x2013;870. doi: 10.1007/s12192-019-01005-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-019-01005-y</ArticleId><ArticleId IdType="pmc">PMC6717175</ArticleId><ArticleId IdType="pubmed">31168740</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuta R., Larochelle N., Fernandez M., Pal A., Minotti S., Tibshirani M., St Louis K., Gentil B.J., Nalbantoglu J.N., Hermann A., et al. Depending on the stress, histone deacetylase inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS models. Cell Stress Chaperones. 2020;25:173&#x2013;191. doi: 10.1007/s12192-019-01064-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-019-01064-1</ArticleId><ArticleId IdType="pmc">PMC6985055</ArticleId><ArticleId IdType="pubmed">31900865</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu P., Liu L., Gong Z., Tan H., Wang F., Yuan J., Feng Y., Wei Q., Tanguay R.M., Wu T. Overexpressed heat shock protein 70 protects cells against DNA damage caused by ultraviolet C in a dose-dependent manner. Cell Stress Chaperones. 2006;11:162&#x2013;169. doi: 10.1379/CSC-175R.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1379/CSC-175R.1</ArticleId><ArticleId IdType="pmc">PMC1484517</ArticleId><ArticleId IdType="pubmed">16817322</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishor A., White E.J.F., Matsangos A.E., Yan Z., Tandukar B., Wilson G.M. Hsp70&#x2019;s RNA-binding and mRNA-stabilizing activities are independent of its protein chaperone functions. J. Biol. Chem. 2017;292:14122&#x2013;14133. doi: 10.1074/jbc.M117.785394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.785394</ArticleId><ArticleId IdType="pmc">PMC5572911</ArticleId><ArticleId IdType="pubmed">28679534</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters R.W., Parker R. Coupling of Ribostasis and Proteostasis: Hsp70 Proteins in mRNA Metabolism. Trends Biochem. Sci. 2015;40:552&#x2013;559. doi: 10.1016/j.tibs.2015.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2015.08.004</ArticleId><ArticleId IdType="pmc">PMC4584423</ArticleId><ArticleId IdType="pubmed">26410596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Wang P., Zhang S., Liu W., Lv X., Shi D., Zhao L., Liu H., Wang B., Chen S., et al. HSP70 attenuates compression-induced apoptosis of nucleus pulposus cells by suppressing mitochondrial fission via upregulating the expression of SIRT3. Exp. Mol. Med. 2022;54:309&#x2013;323. doi: 10.1038/s12276-022-00745-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-022-00745-9</ArticleId><ArticleId IdType="pmc">PMC8980024</ArticleId><ArticleId IdType="pubmed">35338257</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Yu Y., Gorshkov B., Haigh S., Bordan Z., Weintraub D., Rudic R.D., Chakraborty T., Barman S.A., Verin A.D., et al. Hsp70 Suppresses Mitochondrial Reactive Oxygen Species and Preserves Pulmonary Microvascular Barrier Integrity Following Exposure to Bacterial Toxins. Front. Immunol. 2018;9:1309. doi: 10.3389/fimmu.2018.01309.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01309</ArticleId><ArticleId IdType="pmc">PMC6008539</ArticleId><ArticleId IdType="pubmed">29951058</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Yang J., Wang Y., Liu Q., Cheng J., Wang F. Neuroprotective effects of increasing levels of HSP70 against neuroinflammation in Parkinson&#x2019;s disease model by inhibition of NF-kappaB and STAT3. Life Sci. 2019;234:116747. doi: 10.1016/j.lfs.2019.116747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.116747</ArticleId><ArticleId IdType="pubmed">31408661</ArticleId></ArticleIdList></Reference><Reference><Citation>Gifondorwa D.J., Robinson M.B., Hayes C.D., Taylor A.R., Prevette D.M., Oppenheim R.W., Caress J., Milligan C.E. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2007;27:13173&#x2013;13180. doi: 10.1523/JNEUROSCI.4057-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4057-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673412</ArticleId><ArticleId IdType="pubmed">18045911</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M.K., Sharma B., Tiwari P.K. The small heat shock protein Hsp27: Present understanding and future prospects. J. Therm. Biol. 2017;69:149&#x2013;154. doi: 10.1016/j.jtherbio.2017.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtherbio.2017.06.004</ArticleId><ArticleId IdType="pubmed">29037376</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehlen P., Hickey E., Weber L.A., Arrigo A.P. Large unphosphorylated aggregates as the active form of hsp27 which controls intracellular reactive oxygen species and glutathione levels and generates a protection against TNFalpha in NIH-3T3-ras cells. Biochem. Biophys. Res. Commun. 1997;241:187&#x2013;192. doi: 10.1006/bbrc.1997.7635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1997.7635</ArticleId><ArticleId IdType="pubmed">9405255</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng S., Liang Y., Li L., Tan Y., Liu Q., Liu T., Lu X. Revisiting the Old Data of Heat Shock Protein 27 Expression in Squamous Cell Carcinoma: Enigmatic HSP27, More Than Heat Shock. Cells. 2022;11:1665. doi: 10.3390/cells11101665.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11101665</ArticleId><ArticleId IdType="pmc">PMC9139513</ArticleId><ArticleId IdType="pubmed">35626702</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidyasagar A., Wilson N.A., Djamali A. Heat shock protein 27 (HSP27): Biomarker of disease and therapeutic target. Fibrogenesis Tissue Repair. 2012;5:7. doi: 10.1186/1755-1536-5-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-1536-5-7</ArticleId><ArticleId IdType="pmc">PMC3464729</ArticleId><ArticleId IdType="pubmed">22564335</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S., Hu J., Arogundade O.A., Goginashvili A., Vazquez-Sanchez S., Diedrich J.K., Gu J., Blum J., Oung S., Ye Q., et al. Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition. Nat. Cell Biol. 2022;24:1378&#x2013;1393. doi: 10.1038/s41556-022-00988-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-022-00988-8</ArticleId><ArticleId IdType="pmc">PMC9872726</ArticleId><ArticleId IdType="pubmed">36075972</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Zhang S., Gu J., Tong Y., Li Y., Gui X., Long H., Wang C., Zhao C., Lu J., et al. Hsp27 chaperones FUS phase separation under the modulation of stress-induced phosphorylation. Nat. Struct. Mol. Biol. 2020;27:363&#x2013;372. doi: 10.1038/s41594-020-0399-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-0399-3</ArticleId><ArticleId IdType="pubmed">32231288</ArticleId></ArticleIdList></Reference><Reference><Citation>Mordes D.A., Prudencio M., Goodman L.D., Klim J.R., Moccia R., Limone F., Pietilainen O., Chowdhary K., Dickson D.W., Rademakers R., et al. Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients. Acta Neuropathol. Commun. 2018;6:55. doi: 10.1186/s40478-018-0555-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0555-8</ArticleId><ArticleId IdType="pmc">PMC6031111</ArticleId><ArticleId IdType="pubmed">29973287</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerbury J.J., Gower D., Vanags L., Roberts K., Lee J.A., Ecroyd H. The small heat shock proteins alphaB-crystallin and Hsp27 suppress SOD1 aggregation in vitro. Cell Stress Chaperones. 2013;18:251&#x2013;257. doi: 10.1007/s12192-012-0371-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-012-0371-1</ArticleId><ArticleId IdType="pmc">PMC3581626</ArticleId><ArticleId IdType="pubmed">22993064</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp P.S., Akbar M.T., Bouri S., Senda A., Joshi K., Chen H.J., Latchman D.S., Wells D.J., de Belleroche J. Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression. Neurobiol. Dis. 2008;30:42&#x2013;55. doi: 10.1016/j.nbd.2007.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.12.002</ArticleId><ArticleId IdType="pubmed">18255302</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan J., Lemmens R., Robberecht W., Van Den Bosch L. Role of heat shock response and Hsp27 in mutant SOD1-dependent cell death. Exp. Neurol. 2006;200:301&#x2013;310. doi: 10.1016/j.expneurol.2006.02.135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2006.02.135</ArticleId><ArticleId IdType="pubmed">16806187</ArticleId></ArticleIdList></Reference><Reference><Citation>Read D.E., Gorman A.M. Heat shock protein 27 in neuronal survival and neurite outgrowth. Biochem. Biophys. Res. Commun. 2009;382:6&#x2013;8. doi: 10.1016/j.bbrc.2009.02.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.02.114</ArticleId><ArticleId IdType="pubmed">19249290</ArticleId></ArticleIdList></Reference><Reference><Citation>An J.J., Lee Y.P., Kim D.W., Sohn E.J., Jeong H.J., Kang H.W., Shin M.J., Kim M.J., Ahn E.H., Jang S.H., et al. Transduced HSP27 protein protects neuronal cell death by enhancing FALS-associated SOD1 mutant activity. BMB Rep. 2009;42:136&#x2013;141. doi: 10.5483/BMBRep.2009.42.3.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2009.42.3.136</ArticleId><ArticleId IdType="pubmed">19335999</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan J., Vannuvel K., Andries M., Waelkens E., Robberecht W., Van Den Bosch L. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2008;106:2170&#x2013;2183. doi: 10.1111/j.1471-4159.2008.05545.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05545.x</ArticleId><ArticleId IdType="pubmed">18624915</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsogiannou M., Andrieu C., Baylot V., Baudot A., Dusetti N.J., Gayet O., Finetti P., Garrido C., Birnbaum D., Bertucci F., et al. The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets. Mol. Cell Proteomics. 2014;13:3585&#x2013;3601. doi: 10.1074/mcp.M114.041228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M114.041228</ArticleId><ArticleId IdType="pmc">PMC4256507</ArticleId><ArticleId IdType="pubmed">25277244</ArticleId></ArticleIdList></Reference><Reference><Citation>Sottile M.L., Nadin S.B. Heat shock proteins and DNA repair mechanisms: An updated overview. Cell Stress Chaperones. 2018;23:303&#x2013;315. doi: 10.1007/s12192-017-0843-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-017-0843-4</ArticleId><ArticleId IdType="pmc">PMC5904076</ArticleId><ArticleId IdType="pubmed">28952019</ArticleId></ArticleIdList></Reference><Reference><Citation>Le T.K., Cherif C., Omabe K., Paris C., Lannes F., Audebert S., Baudelet E., Hamimed M., Barbolosi D., Finetti P., et al. DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer. Mol. Ther. 2022;31:471&#x2013;486. doi: 10.1016/j.ymthe.2022.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2022.08.005</ArticleId><ArticleId IdType="pmc">PMC9931527</ArticleId><ArticleId IdType="pubmed">35965411</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman M.J., Li S., Li X.J. Activation of gene transcription by heat shock protein 27 may contribute to its neuronal protection. J. Biol. Chem. 2009;284:27944&#x2013;27951. doi: 10.1074/jbc.M109.037937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.037937</ArticleId><ArticleId IdType="pmc">PMC2788846</ArticleId><ArticleId IdType="pubmed">19656944</ArticleId></ArticleIdList></Reference><Reference><Citation>Doerwald L., van Genesen S.T., Onnekink C., Marin-Vinader L., de Lange F., de Jong W.W., Lubsen N.H. The effect of alphaB-crystallin and Hsp27 on the availability of translation initiation factors in heat-shocked cells. Cell Mol. Life Sci. 2006;63:735&#x2013;743. doi: 10.1007/s00018-005-5582-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-005-5582-5</ArticleId><ArticleId IdType="pubmed">16505970</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S., Wang Y., Zhang X., Kong Q., Li C., Li Y., Ding Z., Liu L. HSP27 Alleviates Cardiac Aging in Mice via a Mechanism Involving Antioxidation and Mitophagy Activation. Oxid. Med. Cell Longev. 2016;2016:2586706. doi: 10.1155/2016/2586706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/2586706</ArticleId><ArticleId IdType="pmc">PMC4821973</ArticleId><ArticleId IdType="pubmed">27110324</ArticleId></ArticleIdList></Reference><Reference><Citation>Sur R., Lyte P.A., Southall M.D. Hsp27 regulates pro-inflammatory mediator release in keratinocytes by modulating NF-kappaB signaling. J. Investig. Derm. 2008;128:1116&#x2013;1122. doi: 10.1038/sj.jid.5701157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.jid.5701157</ArticleId><ArticleId IdType="pubmed">18007587</ArticleId></ArticleIdList></Reference><Reference><Citation>Heilman P.L., Song S., Miranda C.J., Meyer K., Srivastava A.K., Knapp A., Wier C.G., Kaspar B.K., Kolb S.J. HSPB1 mutations causing hereditary neuropathy in humans disrupt non-cell autonomous protection of motor neurons. Exp. Neurol. 2017;297:101&#x2013;109. doi: 10.1016/j.expneurol.2017.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.08.002</ArticleId><ArticleId IdType="pmc">PMC5612892</ArticleId><ArticleId IdType="pubmed">28797631</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu X.B., Shao Y.M., Miao S., Wang L. The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cell Mol. Life Sci. 2006;63:2560&#x2013;2570. doi: 10.1007/s00018-006-6192-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-006-6192-6</ArticleId><ArticleId IdType="pubmed">16952052</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhan S.M.K., Howrigan D.P., Abbott L.E., Klim J.R., Topp S.D., Byrnes A.E., Churchhouse C., Phatnani H., Smith B.N., Rampersaud E., et al. Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein. Nat. Neurosci. 2019;22:1966&#x2013;1974. doi: 10.1038/s41593-019-0530-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0530-0</ArticleId><ArticleId IdType="pmc">PMC6919277</ArticleId><ArticleId IdType="pubmed">31768050</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Zhao X., Liu Q., Zhang K., Liu S., Wang Z., Yang X., Shang L., Cui L., Zhang X. Mutations of DNAJC7 are rare in Chinese amyotrophic lateral sclerosis patients. Amyotroph Lateral. Scler. Front. Degener. 2021;22:312&#x2013;315. doi: 10.1080/21678421.2020.1813314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1813314</ArticleId><ArticleId IdType="pubmed">32897108</ArticleId></ArticleIdList></Reference><Reference><Citation>Jih K.Y., Tsai P.C., Tsai Y.S., Liao Y.C., Lee Y.C. Rapid progressive ALS in a patient with a DNAJC7 loss-of-function mutation. Neurol. Genet. 2020;6:e503. doi: 10.1212/NXG.0000000000000503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000503</ArticleId><ArticleId IdType="pmc">PMC7524575</ArticleId><ArticleId IdType="pubmed">33062890</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohnai G., Nakamura R., Atsuta N., Nakatochi M., Hayashi N., Ito D., Watanabe H., Watanabe H., Katsuno M., Izumi Y., et al. Mutation screening of the DNAJC7 gene in Japanese patients with sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2022;113:131&#x2013;136. doi: 10.1016/j.neurobiolaging.2021.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2021.12.002</ArticleId><ArticleId IdType="pubmed">35039179</ArticleId></ArticleIdList></Reference><Reference><Citation>Novoselov S.S., Mustill W.J., Gray A.L., Dick J.R., Kanuga N., Kalmar B., Greensmith L., Cheetham M.E. Molecular chaperone mediated late-stage neuroprotection in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. PLoS ONE. 2013;8:e73944. doi: 10.1371/journal.pone.0073944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073944</ArticleId><ArticleId IdType="pmc">PMC3758296</ArticleId><ArticleId IdType="pubmed">24023695</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi H., Kobayashi Y., Yoshihara T., Niwa J., Doyu M., Ohtsuka K., Sobue G. Hsp70 and Hsp40 improve neurite outgrowth and suppress intracytoplasmic aggregate formation in cultured neuronal cells expressing mutant SOD1. Brain Res. 2002;949:11&#x2013;22. doi: 10.1016/S0006-8993(02)02568-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(02)02568-4</ArticleId><ArticleId IdType="pubmed">12213295</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.J., Mitchell J.C., Novoselov S., Miller J., Nishimura A.L., Scotter E.L., Vance C.A., Cheetham M.E., Shaw C.E. The heat shock response plays an important role in TDP-43 clearance: Evidence for dysfunction in amyotrophic lateral sclerosis. Brain. 2016;139:1417&#x2013;1432. doi: 10.1093/brain/aww028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww028</ArticleId><ArticleId IdType="pmc">PMC4845254</ArticleId><ArticleId IdType="pubmed">26936937</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.K., Hong J.Y., Arslan F., Kanneganti V., Patel B., Tietsort A., Tank E.M.H., Li X., Barmada S.J., Liebman S.W. Overexpression of the essential Sis1 chaperone reduces TDP-43 effects on toxicity and proteolysis. PLoS Genet. 2017;13:e1006805. doi: 10.1371/journal.pgen.1006805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006805</ArticleId><ArticleId IdType="pmc">PMC5460882</ArticleId><ArticleId IdType="pubmed">28531192</ArticleId></ArticleIdList></Reference><Reference><Citation>Udan-Johns M., Bengoechea R., Bell S., Shao J., Diamond M.I., True H.L., Weihl C.C., Baloh R.H. Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones. Hum. Mol. Genet. 2014;23:157&#x2013;170. doi: 10.1093/hmg/ddt408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt408</ArticleId><ArticleId IdType="pmc">PMC3857952</ArticleId><ArticleId IdType="pubmed">23962724</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.G., Takahama S., Zhang G., Tomarev S.I., Ye Y. Unconventional secretion of misfolded proteins promotes adaptation to proteasome dysfunction in mammalian cells. Nat. Cell Biol. 2016;18:765&#x2013;776. doi: 10.1038/ncb3372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3372</ArticleId><ArticleId IdType="pubmed">27295555</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Xu Y., Zhang T., Cui L., Saidi L., Ye Y. Secretion of misfolded cytosolic proteins from mammalian cells is independent of chaperone-mediated autophagy. J. Biol. Chem. 2018;293:14359&#x2013;14370. doi: 10.1074/jbc.RA118.003660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003660</ArticleId><ArticleId IdType="pmc">PMC6139554</ArticleId><ArticleId IdType="pubmed">30072379</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontaine S.N., Zheng D., Sabbagh J.J., Martin M.D., Chaput D., Darling A., Trotter J.H., Stothert A.R., Nordhues B.A., Lussier A., et al. DnaJ/Hsc70 chaperone complexes control the extracellular release of neurodegenerative-associated proteins. EMBO J. 2016;35:1537&#x2013;1549. doi: 10.15252/embj.201593489.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593489</ArticleId><ArticleId IdType="pmc">PMC4946142</ArticleId><ArticleId IdType="pubmed">27261198</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Cui L., Dibello A., Wang L., Lee J., Saidi L., Lee J.G., Ye Y. DNAJC5 facilitates USP19-dependent unconventional secretion of misfolded cytosolic proteins. Cell Discov. 2018;4:11. doi: 10.1038/s41421-018-0012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-018-0012-7</ArticleId><ArticleId IdType="pmc">PMC5838229</ArticleId><ArticleId IdType="pubmed">29531792</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce M.M.P., Spartz E.J., Hong W., Luo L., Kopito R.R. Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain. Nat. Commun. 2015;6:6768. doi: 10.1038/ncomms7768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7768</ArticleId><ArticleId IdType="pmc">PMC4515032</ArticleId><ArticleId IdType="pubmed">25866135</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo J.A., Liu T., Trotter C., Fang C.C., De Narvaez E., LePochat P., Maslar D., Bukhari A., Zhao X., Deonarine A., et al. Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity. Nat. Commun. 2017;8:15558. doi: 10.1038/ncomms15558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15558</ArticleId><ArticleId IdType="pmc">PMC5467170</ArticleId><ArticleId IdType="pubmed">28585542</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitoh H., Kadowaki H., Nagai A., Maruyama T., Yokota T., Fukutomi H., Noguchi T., Matsuzawa A., Takeda K., Ichijo H. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 2008;22:1451&#x2013;1464. doi: 10.1101/gad.1640108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1640108</ArticleId><ArticleId IdType="pmc">PMC2418582</ArticleId><ArticleId IdType="pubmed">18519638</ArticleId></ArticleIdList></Reference><Reference><Citation>Montibeller L., de Belleroche J. Amyotrophic lateral sclerosis (ALS) and Alzheimer&#x2019;s disease (AD) are characterised by differential activation of ER stress pathways: Focus on UPR target genes. Cell Stress Chaperones. 2018;23:897&#x2013;912. doi: 10.1007/s12192-018-0897-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-018-0897-y</ArticleId><ArticleId IdType="pmc">PMC6111088</ArticleId><ArticleId IdType="pubmed">29725981</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnke J., Feige M.J., Hendershot L.M. BiP and its nucleotide exchange factors Grp170 and Sil1: Mechanisms of action and biological functions. J. Mol. Biol. 2015;427:1589&#x2013;1608. doi: 10.1016/j.jmb.2015.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2015.02.011</ArticleId><ArticleId IdType="pmc">PMC4356644</ArticleId><ArticleId IdType="pubmed">25698114</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillis J., Schipper-Krom S., Juenemann K., Gruber A., Coolen S., van den Nieuwendijk R., van Veen H., Overkleeft H., Goedhart J., Kampinga H.H., et al. The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides. J. Biol. Chem. 2013;288:17225&#x2013;17237. doi: 10.1074/jbc.M112.421685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.421685</ArticleId><ArticleId IdType="pmc">PMC3682527</ArticleId><ArticleId IdType="pubmed">23612975</ArticleId></ArticleIdList></Reference><Reference><Citation>Aprile F.A., Kallstig E., Limorenko G., Vendruscolo M., Ron D., Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress alpha-synuclein aggregation. Sci. Rep. 2017;7:9039. doi: 10.1038/s41598-017-08324-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-08324-z</ArticleId><ArticleId IdType="pmc">PMC5567236</ArticleId><ArticleId IdType="pubmed">28831037</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung J., Behrends C. Multifaceted role of SMCR8 as autophagy regulator. Small GTPases. 2020;11:53&#x2013;61. doi: 10.1080/21541248.2017.1346553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541248.2017.1346553</ArticleId><ArticleId IdType="pmc">PMC6959302</ArticleId><ArticleId IdType="pubmed">28696821</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodier J.L., Soares A.O., Pereira G.C., DeVine L.R., Sanchez L., Cole R.N., Garcia-Perez J.L. C9orf72-associated SMCR8 protein binds in the ubiquitin pathway and with proteins linked with neurological disease. Acta Neuropathol. Commun. 2020;8:110. doi: 10.1186/s40478-020-00982-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00982-x</ArticleId><ArticleId IdType="pmc">PMC7364817</ArticleId><ArticleId IdType="pubmed">32678027</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y., Stoynov S., Mahamid J., Saha S., Franzmann T.M., et al. A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Levone B.R., Lenzken S.C., Antonaci M., Maiser A., Rapp A., Conte F., Reber S., Mechtersheimer J., Ronchi A.E., Muhlemann O., et al. FUS-dependent liquid-liquid phase separation is important for DNA repair initiation. J. Cell Biol. 2021;220:e202008030. doi: 10.1083/jcb.202008030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202008030</ArticleId><ArticleId IdType="pmc">PMC7953258</ArticleId><ArticleId IdType="pubmed">33704371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Han T.W., Xie S., Shi K., Du X., Wu L.C., Mirzaei H., Goldsmith E.J., Longgood J., Pei J., et al. Cell-free formation of RNA granules: Low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012;149:753&#x2013;767. doi: 10.1016/j.cell.2012.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.017</ArticleId><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E., Boeynaems S., Kato M., Guo L., Caulfield T.R., Steyaert J., Scheveneels W., Wilmans N., Haeck W., Hersmus N., et al. Molecular Dissection of FUS Points at Synergistic Effect of Low-Complexity Domains in Toxicity. Cell Rep. 2018;24:529&#x2013;537.e4. doi: 10.1016/j.celrep.2018.06.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.06.070</ArticleId><ArticleId IdType="pmc">PMC6077250</ArticleId><ArticleId IdType="pubmed">30021151</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Liu Z., Zhang S., Li Y., Xia W., Wang C., Xiang H., Liu Z., Tan L., Fang Y., et al. Hsp40 proteins phase separate to chaperone the assembly and maintenance of membraneless organelles. Proc. Natl. Acad. Sci. USA. 2020;117:31123&#x2013;31133. doi: 10.1073/pnas.2002437117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2002437117</ArticleId><ArticleId IdType="pmc">PMC7733851</ArticleId><ArticleId IdType="pubmed">33229560</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.K., Arslan F., Kanneganti V., Barmada S.J., Purushothaman P., Verma S.C., Liebman S.W. Overexpression of a conserved HSP40 chaperone reduces toxicity of several neurodegenerative disease proteins. Prion. 2018;12:16&#x2013;22. doi: 10.1080/19336896.2017.1423185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2017.1423185</ArticleId><ArticleId IdType="pmc">PMC5871033</ArticleId><ArticleId IdType="pubmed">29308690</ArticleId></ArticleIdList></Reference><Reference><Citation>Nillegoda N.B., Kirstein J., Szlachcic A., Berynskyy M., Stank A., Stengel F., Arnsburg K., Gao X., Scior A., Aebersold R., et al. Crucial HSP70 co-chaperone complex unlocks metazoan protein disaggregation. Nature. 2015;524:247&#x2013;251. doi: 10.1038/nature14884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14884</ArticleId><ArticleId IdType="pmc">PMC4830470</ArticleId><ArticleId IdType="pubmed">26245380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioakeimidis F., Ott C., Kozjak-Pavlovic V., Violitzi F., Rinotas V., Makrinou E., Eliopoulos E., Fasseas C., Kollias G., Douni E. A splicing mutation in the novel mitochondrial protein DNAJC11 causes motor neuron pathology associated with cristae disorganization, and lymphoid abnormalities in mice. PLoS ONE. 2014;9:e104237. doi: 10.1371/journal.pone.0104237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0104237</ArticleId><ArticleId IdType="pmc">PMC4128653</ArticleId><ArticleId IdType="pubmed">25111180</ArticleId></ArticleIdList></Reference><Reference><Citation>Elwi A.N., Lee B., Meijndert H.C., Braun J.E., Kim S.W. Mitochondrial chaperone DnaJA3 induces Drp1-dependent mitochondrial fragmentation. Int. J. Biochem. Cell Biol. 2012;44:1366&#x2013;1376. doi: 10.1016/j.biocel.2012.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2012.05.004</ArticleId><ArticleId IdType="pubmed">22595283</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumada K., Fuse N., Tamura T., Okamori C., Kurata S. HSP70/DNAJA3 chaperone/cochaperone regulates NF-kappaB activity in immune responses. Biochem. Biophys. Res. Commun. 2019;513:947&#x2013;951. doi: 10.1016/j.bbrc.2019.04.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.04.077</ArticleId><ArticleId IdType="pubmed">31005254</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluder I.T., Nitika , Knighton L.E., Truman A.W. The Hsp70 co-chaperone Ydj1/HDJ2 regulates ribonucleotide reductase activity. PLoS Genet. 2018;14:e1007462. doi: 10.1371/journal.pgen.1007462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007462</ArticleId><ArticleId IdType="pmc">PMC6277125</ArticleId><ArticleId IdType="pubmed">30452489</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyc J., Klingbeil M.M., Lukes J. Mitochondrial heat shock protein machinery hsp70/hsp40 is indispensable for proper mitochondrial DNA maintenance and replication. mBio. 2015;6 doi: 10.1128/mBio.02425-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02425-14</ArticleId><ArticleId IdType="pmc">PMC4337576</ArticleId><ArticleId IdType="pubmed">25670781</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos M.J., Hageman J., Carra S., Kampinga H.H. Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry. 2008;47:7001&#x2013;7011. doi: 10.1021/bi800639z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi800639z</ArticleId><ArticleId IdType="pubmed">18557634</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z., Chen L., Zhang J., Li T., Tang J., Xu N., Wang X. Structure, function, property, and role in neurologic diseases and other diseases of the sHsp22. J. Neurosci. Res. 2007;85:2071&#x2013;2079. doi: 10.1002/jnr.21231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.21231</ArticleId><ArticleId IdType="pubmed">17304582</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V., Sau D., Rusmini P., Boncoraglio A., Onesto E., Bolzoni E., Galbiati M., Fontana E., Marino M., Carra S., et al. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS) Hum. Mol. Genet. 2010;19:3440&#x2013;3456. doi: 10.1093/hmg/ddq257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq257</ArticleId><ArticleId IdType="pubmed">20570967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganassi M., Mateju D., Bigi I., Mediani L., Poser I., Lee H.O., Seguin S.J., Morelli F.F., Vinet J., Leo G., et al. A Surveillance Function of the HSPB8-BAG3-HSP70 Chaperone Complex Ensures Stress Granule Integrity and Dynamism. Mol. Cell. 2016;63:796&#x2013;810. doi: 10.1016/j.molcel.2016.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.07.021</ArticleId><ArticleId IdType="pubmed">27570075</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilbert S.M., Lambert H., Rodrigue M.A., Fuchs M., Landry J., Lavoie J.N. HSPB8 and BAG3 cooperate to promote spatial sequestration of ubiquitinated proteins and coordinate the cellular adaptive response to proteasome insufficiency. FASEB J. 2018;32:3518&#x2013;3535. doi: 10.1096/fj.201700558RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700558RR</ArticleId><ArticleId IdType="pubmed">29405094</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Tan J., Zhou F., Hu Z., Yang B. Heat Shock Protein B8 (HSPB8) Reduces Oxygen-Glucose Deprivation/Reperfusion Injury via the Induction of Mitophagy. Cell Physiol. Biochem. 2018;48:1492&#x2013;1504. doi: 10.1159/000492259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000492259</ArticleId><ArticleId IdType="pubmed">30071537</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Yang B., Li T., Gong X., Zhou F., Hu Z. HSPB8 over-expression prevents disruption of blood-brain barrier by promoting autophagic flux after cerebral ischemia/reperfusion injury. J. Neurochem. 2019;148:97&#x2013;113. doi: 10.1111/jnc.14626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14626</ArticleId><ArticleId IdType="pubmed">30422312</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y., Wu Y., Jiang X., Zhu J., Wang C., Ma R., Li G. HSPB8 Overexpression Ameliorates Cognitive Impairment in Diabetic Mice via Inhibiting NLRP3 Inflammation Activation. Oxid. Med. Cell Longev. 2022;2022:9251835. doi: 10.1155/2022/9251835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/9251835</ArticleId><ArticleId IdType="pmc">PMC9359860</ArticleId><ArticleId IdType="pubmed">35958024</ArticleId></ArticleIdList></Reference><Reference><Citation>Deora V., Lee J.D., Albornoz E.A., McAlary L., Jagaraj C.J., Robertson A.A.B., Atkin J.D., Cooper M.A., Schroder K., Yerbury J.J., et al. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia. 2020;68:407&#x2013;421. doi: 10.1002/glia.23728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23728</ArticleId><ArticleId IdType="pubmed">31596526</ArticleId></ArticleIdList></Reference><Reference><Citation>Carra S., Seguin S.J., Lambert H., Landry J. HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy. J. Biol. Chem. 2008;283:1437&#x2013;1444. doi: 10.1074/jbc.M706304200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M706304200</ArticleId><ArticleId IdType="pubmed">18006506</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturner E., Behl C. The Role of the Multifunctional BAG3 Protein in Cellular Protein Quality Control and in Disease. Front. Mol. Neurosci. 2017;10:177. doi: 10.3389/fnmol.2017.00177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00177</ArticleId><ArticleId IdType="pmc">PMC5478690</ArticleId><ArticleId IdType="pubmed">28680391</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V., D&#x2019;Agostino V.G., Cristofani R., Rusmini P., Cicardi M.E., Messi E., Loffredo R., Pancher M., Piccolella M., Galbiati M., et al. Transcriptional induction of the heat shock protein B8 mediates the clearance of misfolded proteins responsible for motor neuron diseases. Sci. Rep. 2016;6:22827. doi: 10.1038/srep22827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep22827</ArticleId><ArticleId IdType="pmc">PMC4785366</ArticleId><ArticleId IdType="pubmed">26961006</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., Crippa V., Cereda C., Bonetto V., Zucchi E., Gessani A., Ceroni M., Chio A., D&#x2019;Amico R., Monsurro M.R., et al. Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS) BMJ Open. 2019;9:e028486. doi: 10.1136/bmjopen-2018-028486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-028486</ArticleId><ArticleId IdType="pmc">PMC6549675</ArticleId><ArticleId IdType="pubmed">31152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Chierichetti M., Cerretani M., Ciammaichella A., Crippa V., Rusmini P., Ferrari V., Tedesco B., Casarotto E., Cozzi M., Mina F., et al. Identification of HSPB8 modulators counteracting misfolded protein accumulation in neurodegenerative diseases. Life Sci. 2022;322:121323. doi: 10.1016/j.lfs.2022.121323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2022.121323</ArticleId><ArticleId IdType="pubmed">36574942</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorter R.P., Stephenson J., Nutma E., Anink J., de Jonge J.C., Baron W., Jahreibeta M.C., Belien J.A.M., van Noort J.M., Mijnsbergen C., et al. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes. Neuropathol Appl. Neurobiol. 2019;45:459&#x2013;475. doi: 10.1111/nan.12525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12525</ArticleId><ArticleId IdType="pmc">PMC7379307</ArticleId><ArticleId IdType="pubmed">30346063</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R., Crippa V., Vezzoli G., Rusmini P., Galbiati M., Cicardi M.E., Meroni M., Ferrari V., Tedesco B., Piccolella M., et al. The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases. Cell Stress Chaperones. 2018;23:1&#x2013;12. doi: 10.1007/s12192-017-0806-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-017-0806-9</ArticleId><ArticleId IdType="pmc">PMC5741577</ArticleId><ArticleId IdType="pubmed">28608264</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann D.M., Rollinson S., Robinson A., Bennion Callister J., Thompson J.C., Snowden J.S., Gendron T., Petrucelli L., Masuda-Suzukake M., Hasegawa M., et al. Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol. Commun. 2013;1:68. doi: 10.1186/2051-5960-1-68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-68</ArticleId><ArticleId IdType="pmc">PMC3893586</ArticleId><ArticleId IdType="pubmed">24252525</ArticleId></ArticleIdList></Reference><Reference><Citation>Boczek E.E., Fursch J., Niedermeier M.L., Jawerth L., Jahnel M., Ruer-Gruss M., Kammer K.M., Heid P., Mediani L., Wang J., et al. HspB8 prevents aberrant phase transitions of FUS by chaperoning its folded RNA-binding domain. Elife. 2021;10:e69377. doi: 10.7554/eLife.69377.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.69377</ArticleId><ArticleId IdType="pmc">PMC8510580</ArticleId><ArticleId IdType="pubmed">34487489</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter J. Designer protein disaggregases to counter neurodegenerative disease. Curr. Opin Genet. Dev. 2017;44:1&#x2013;8. doi: 10.1016/j.gde.2017.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2017.01.008</ArticleId><ArticleId IdType="pmc">PMC5447488</ArticleId><ArticleId IdType="pubmed">28208059</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack K.L., Shorter J. Engineering and Evolution of Molecular Chaperones and Protein Disaggregases with Enhanced Activity. Front. Mol. Biosci. 2016;3:8. doi: 10.3389/fmolb.2016.00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2016.00008</ArticleId><ArticleId IdType="pmc">PMC4791398</ArticleId><ArticleId IdType="pubmed">27014702</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N. Engl. J. Med. 1994;330:585&#x2013;591. doi: 10.1056/NEJM199403033300901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing G., Edaravone A.L.S.S.G. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Watkins C., Cawson M., Hendrix S., Dickson S.P., Knowlton N., Timmons J., Manuel M., Cudkowicz M. Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes. Muscle Nerve. 2022;66:136&#x2013;141. doi: 10.1002/mus.27569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27569</ArticleId><ArticleId IdType="pmc">PMC9540225</ArticleId><ArticleId IdType="pubmed">35508892</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascuzzi R., Bodkin C., Snook R., Farlow M., Guingrich S., Micheels A., Gu H., Yang S., Johnstone B., Du Y. CC100 Phase 1 Multiple Dose Study in Patients with ALS (5189) Neurology. 2020;94:5189.</Citation></Reference><Reference><Citation>Stahli A., Maheen C.U., Strauss F.J., Eick S., Sculean A., Gruber R. Caffeic acid phenethyl ester protects against oxidative stress and dampens inflammation via heme oxygenase 1. Int. J. Oral Sci. 2019;11:6. doi: 10.1038/s41368-018-0039-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41368-018-0039-5</ArticleId><ArticleId IdType="pmc">PMC6381107</ArticleId><ArticleId IdType="pubmed">30783082</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontanilla C.V., Wei X., Zhao L., Johnstone B., Pascuzzi R.M., Farlow M.R., Du Y. Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis. Neuroscience. 2012;205:185&#x2013;193. doi: 10.1016/j.neuroscience.2011.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2011.12.025</ArticleId><ArticleId IdType="pubmed">22206942</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.C., Liao L.X., Lv H.N., Liu D., Dong W., Zhu J., Chen J.F., Shi M.L., Fu G., Song X.M., et al. Highly Selective Activation of Heat Shock Protein 70 by Allosteric Regulation Provides an Insight into Efficient Neuroinflammation Inhibition. EBioMedicine. 2017;23:160&#x2013;172. doi: 10.1016/j.ebiom.2017.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2017.08.011</ArticleId><ArticleId IdType="pmc">PMC5605382</ArticleId><ArticleId IdType="pubmed">28807514</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang A.N., Liang M., Dominguez-Meijide A., Masaracchia C., Goeckeler-Fried J.L., Mazzone C.S., Newhouse D.W., Kendsersky N.M., Yates M.E., Manos-Turvey A., et al. Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding. Bioorg. Med. Chem. 2019;27:79&#x2013;91. doi: 10.1016/j.bmc.2018.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2018.11.011</ArticleId><ArticleId IdType="pmc">PMC6298824</ArticleId><ArticleId IdType="pubmed">30528127</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassel J.A., Ilyin S., McDonnell M.E., Reitz A.B. Novel inhibitors of heat shock protein Hsp70-mediated luciferase refolding that bind to DnaJ. Bioorg. Med. Chem. 2012;20:3609&#x2013;3614. doi: 10.1016/j.bmc.2012.03.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2012.03.067</ArticleId><ArticleId IdType="pubmed">22546203</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha L., Bolaender A., Patel H.J., Taldone T. Heat Shock Protein (HSP) Drug Discovery and Development: Targeting Heat Shock Proteins in Disease. Curr. Top Med. Chem. 2016;16:2753&#x2013;2764. doi: 10.2174/1568026616666160413141911.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026616666160413141911</ArticleId><ArticleId IdType="pmc">PMC4995156</ArticleId><ArticleId IdType="pubmed">27072696</ArticleId></ArticleIdList></Reference><Reference><Citation>Licata N.V., Cristofani R., Salomonsson S., Wilson K.M., Kempthorne L., Vaizoglu D., D&#x2019;Agostino V.G., Pollini D., Loffredo R., Pancher M., et al. C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation. EMBO J. 2022;41:e105026. doi: 10.15252/embj.2020105026.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020105026</ArticleId><ArticleId IdType="pmc">PMC8724771</ArticleId><ArticleId IdType="pubmed">34791698</ArticleId></ArticleIdList></Reference><Reference><Citation>Taipale M., Jarosz D.F., Lindquist S. HSP90 at the hub of protein homeostasis: Emerging mechanistic insights. Nat. Rev. Mol. Cell Biol. 2010;11:515&#x2013;528. doi: 10.1038/nrm2918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2918</ArticleId><ArticleId IdType="pubmed">20531426</ArticleId></ArticleIdList></Reference><Reference><Citation>Neef D.W., Turski M.L., Thiele D.J. Modulation of heat shock transcription factor 1 as a therapeutic target for small molecule intervention in neurodegenerative disease. PLoS Biol. 2010;8:e1000291. doi: 10.1371/journal.pbio.1000291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000291</ArticleId><ArticleId IdType="pmc">PMC2808216</ArticleId><ArticleId IdType="pubmed">20098725</ArticleId></ArticleIdList></Reference><Reference><Citation>Marunouchi T., Inomata S., Sanbe A., Takagi N., Tanonaka K. Protective effect of geranylgeranylacetone via enhanced induction of HSPB1 and HSPB8 in mitochondria of the failing heart following myocardial infarction in rats. Eur. J. Pharmacol. 2014;730:140&#x2013;147. doi: 10.1016/j.ejphar.2014.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2014.02.037</ArticleId><ArticleId IdType="pubmed">24631258</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi T., Kumar V., Kaznacheyeva E.V., Jana N.R. Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington&#x2019;s Disease. Mol. Neurobiol. 2021;58:3992&#x2013;4006. doi: 10.1007/s12035-021-02397-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02397-8</ArticleId><ArticleId IdType="pubmed">33904021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Phaneuf D., Julien J.P. Withaferin-A Treatment Alleviates TAR DNA-Binding Protein-43 Pathology and Improves Cognitive Function in a Mouse Model of FTLD. Neurotherapeutics. 2021;18:286&#x2013;296. doi: 10.1007/s13311-020-00952-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-020-00952-0</ArticleId><ArticleId IdType="pmc">PMC8116414</ArticleId><ArticleId IdType="pubmed">33078279</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerheide S.D., Bosman J.D., Mbadugha B.N., Kawahara T.L., Matsumoto G., Kim S., Gu W., Devlin J.P., Silverman R.B., Morimoto R.I. Celastrols as inducers of the heat shock response and cytoprotection. J. Biol. Chem. 2004;279:56053&#x2013;56060. doi: 10.1074/jbc.M409267200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M409267200</ArticleId><ArticleId IdType="pubmed">15509580</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerheide S.D., Morimoto R.I. Heat shock response modulators as therapeutic tools for diseases of protein conformation. J. Biol. Chem. 2005;280:33097&#x2013;33100. doi: 10.1074/jbc.R500010200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R500010200</ArticleId><ArticleId IdType="pubmed">16076838</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M., Wuu J., Andersen P.M., Atassi N., David W., Cudkowicz M., Schoenfeld D. Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS. Neurology. 2018;90:e565&#x2013;e574. doi: 10.1212/WNL.0000000000004960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004960</ArticleId><ArticleId IdType="pmc">PMC5818014</ArticleId><ArticleId IdType="pubmed">29367439</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C., Tran J., Wang H., Park G., Hsu F., Guo Z. Abeta42 fibril formation from predominantly oligomeric samples suggests a link between oligomer heterogeneity and fibril polymorphism. R Soc. Open Sci. 2019;6:190179. doi: 10.1098/rsos.190179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.190179</ArticleId><ArticleId IdType="pmc">PMC6689619</ArticleId><ArticleId IdType="pubmed">31417723</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiti F., Dobson C.M. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu. Rev. Biochem. 2017;86:27&#x2013;68. doi: 10.1146/annurev-biochem-061516-045115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-061516-045115</ArticleId><ArticleId IdType="pubmed">28498720</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>